Exosome-based liquid biopsies in cancer: opportunities and challenges

W. Yu; J. Hurley; D. Roberts; S.K. Chakrabortty; D. Enderle; M. Noerholm; X.O. Breakefield; J.K. Skog

doi:10.1016/j.annonc.2021.01.074

journal article Open Access Apr 01, 2021

Exosome-based liquid biopsies in cancer: opportunities and challenges

W. Yu

J. Hurley D. Roberts S.K. Chakrabortty D. Enderle M. Noerholm X.O. Breakefield J.K. Skog

Annals of Oncology Vol. 32 No. 4 pp. 466-477 · Elsevier BV

View at Publisher Save 10.1016/j.annonc.2021.01.074

Topics

No keywords indexed for this article. Browse by subject →

References

130

[1]

Kandoth "Mutational landscape and significance across 12 major cancer types" Nature (2013) 10.1038/nature12634

[2]

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Marco Gerlinger, Andrew J. Rowan, Stuart Horswell et al.

New England Journal of Medicine 2012 10.1056/nejmoa1113205

[3]

Ding "Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing" Nature (2012) 10.1038/nature10738

[4]

Driessens "Defining the mode of tumour growth by clonal analysis" Nature (2012) 10.1038/nature11344

[5]

Campbell "The patterns and dynamics of genomic instability in metastatic pancreatic cancer" Nature (2010) 10.1038/nature09460

[6]

Tumour evolution inferred by single-cell sequencing

Nicholas Navin, Jude Kendall, Jennifer Troge et al.

Nature 2011 10.1038/nature09807

[7]

Lokhandwala "Costs of diagnostic assessment for lung cancer: a medicare claims analysis" Clin Lung Cancer (2017) 10.1016/j.cllc.2016.07.006

[8]

Leighl "Clinical utility of comprehensive cell-free DNA analysis to identify genomic biomarkers in patients with newly diagnosed metastatic non-small cell lung cancer" Clin Cancer Res (2019) 10.1158/1078-0432.ccr-19-0624

[9]

(2016)

[10]

(2020)

[11]

(2020)

[12]

Haque "Challenges in using ctDNA to achieve early detection of cancer" bioRxiv (2017)

[13]

Bauml "Clonal hematopoiesis: a new layer in the liquid biopsy story in lung cancer" Clin Cancer Res (2018) 10.1158/1078-0432.ccr-18-0969

[14]

Jahn "The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the prostate-specific antigen-era" Int J Cancer (2015) 10.1002/ijc.29408

[15]

Direct detection of early-stage cancers using circulating tumor DNA

Jillian Phallen, Mark Sausen, Vilmos Adleff et al.

Science Translational Medicine 2017 10.1126/scitranslmed.aan2415

[16]

Liu "Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA" Ann Oncol (2020) 10.1016/j.annonc.2020.02.011

[17]

Nassiri "Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes" Nat Med (2020) 10.1038/s41591-020-0932-2

[18]

Cohen "Detection and localization of surgically resectable cancers with a multi-analyte blood test" Science (2018) 10.1126/science.aar3247

[19]

Chalasani "A novel blood-based panel of methylated DNA and protein markers for detection of early-stage hepatocellular carcinoma" Clin Gastroenterol Hepatol (2020)

[20]

Parikh "Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers" Nat Med (2019) 10.1038/s41591-019-0561-9

[21]

Bidard "Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data" Lancet Oncol (2014) 10.1016/s1470-2045(14)70069-5

[22]

Clifton "Monitoring of circulating tumor cell trends in a prospective, randomized, placebo-controlled HER2/neu peptide vaccine trial" J Clin Oncol (2011) 10.1200/jco.2011.29.15_suppl.e11126

[23]

Cohen "Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer" J Clin Oncol (2008) 10.1200/jco.2007.15.8923

[24]

Cristofanilli "Circulating tumor cells, disease progression, and survival in metastatic breast cancer" N Engl J Med (2004) 10.1056/nejmoa040766

[25]

Castro-Giner "Tracking cancer progression: from circulating tumor cells to metastasis" Genome Med (2020) 10.1186/s13073-020-00728-3

[26]

Rodrigues "Circulating tumor cells: come together, right now, over metastasis" Cancer Discov (2018) 10.1158/2159-8290.cd-18-1285

[27]

Liu "Homophilic CD44 interactions mediate tumor cell aggregation and polyclonal metastasis in patient-derived breast cancer models" Cancer Discov (2019) 10.1158/2159-8290.cd-18-0065

[28]

Dawson "Analysis of circulating tumor DNA to monitor metastatic breast cancer" N Engl J Med (2013) 10.1056/nejmoa1213261

[29]

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

Chetan Bettegowda, Mark Sausen, Rebecca J. Leary et al.

Science Translational Medicine 2014 10.1126/scitranslmed.3007094

[30]

(2007)

[31]

Zhang "Meta-analysis of the prognostic value of circulating tumor cells in breast cancer" Clin Cancer Res (2012) 10.1158/1078-0432.ccr-12-1587

[32]

Riethdorf "Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system" Clin Cancer Res (2007) 10.1158/1078-0432.ccr-06-1695

[33]

de Bono "Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer" Clin Cancer Res (2008) 10.1158/1078-0432.ccr-08-0872

[34]

Antonarakis "Androgen receptor splice variant 7 and efficacy of taxane chemotherapy in patients with metastatic castration-resistant prostate cancer" JAMA Oncol (2015) 10.1001/jamaoncol.2015.1341

[35]

Scher "Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data" Lancet Oncol (2009) 10.1016/s1470-2045(08)70340-1

[36]

Rossi "CTCs 2020: great expectations or unreasonable dreams" Cells (2019) 10.3390/cells8090989

[37]

Marchetti "Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment" PLoS One (2014) 10.1371/journal.pone.0103883

[38]

Foroni "When less is more: specific capture and analysis of tumor exosomes in plasma increases the sensitivity of liquid biopsy for comprehensive detection of multiple androgen receptor phenotypes in advanced prostate cancer patients" Biomedicines (2020) 10.3390/biomedicines8050131

[39]

Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells

Khalid Al-Nedawi, Brian Meehan, Johann Micallef et al.

Nature Cell Biology 2008 10.1038/ncb1725

[40]

Manda "Exosomes as a biomarker platform for detecting epidermal growth factor receptor-positive high-grade gliomas" J Neurosurg (2018)

[41]

Skog "Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers" Nat Cell Biol (2008) 10.1038/ncb1800

[42]

Limaye "Multi-analyte liquid biopsies based treatment in advanced refractory cancers" J Clin Oncol (2020) 10.1200/jco.2020.38.15_suppl.e15623

[43]

Krug "Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma" Ann Oncol (2018) 10.1093/annonc/mdy261

[44]

Castellanos-Rizaldos "Exosome-based detection of EGFR T790M in plasma from non-small cell lung cancer patients" Clin Cancer Res (2018) 10.1158/1078-0432.ccr-17-3369

[45]

Möhrmann "Liquid biopsies using plasma exosomal nucleic acids and plasma cell-free DNA compared with clinical outcomes of patients with advanced cancers" Clin Cancer Res (2018) 10.1158/1078-0432.ccr-17-2007

[46]

Figueroa "Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients" Neuro Oncol (2017) 10.1093/neuonc/nox085

[47]

Nimir "Detection of AR-V7 in liquid biopsies of castrate resistant prostate cancer patients: a comparison of AR-V7 analysis in circulating tumor cells, circulating tumor RNA and exosomes" Cells (2019) 10.3390/cells8070688

[48]

The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients

Marzia Del Re, Elisa Biasco, Stefania Crucitta et al.

European Urology 2017 10.1016/j.eururo.2016.08.012

[49]

Cortot "Exon 14 deleted MET receptor as a new biomarker and target in cancers" J Natl Cancer Inst (2017) 10.1093/jnci/djw262

[50]

Nilsson "Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer" Br J Cancer (2009) 10.1038/sj.bjc.6605058

Showing 50 of 130 references

Cited By

765

An Exosome-Based Liquid Biopsy for the Detection of Early-Onset Colorectal Cancer: The ENCODER Multicenter Study

Alessandro Mannucci, Francesc Balaguer · 2026

Gastroenterology

Signatures of Oncosomes as dual-function nanocarriers in targeted drug delivery and early cancer detection

Popat Mohite, Nobendu Mukerjee · 2026

Chemical Engineering Journal

Exosomal Liquid Biopsy in Prostate Cancer: A Systematic Review of Biomarkers for Diagnosis, Prognosis, and Treatment Response

Yameen Hamid, Rukhshana Dina Rabbani · 2025

International Journal of Molecular...

One-Step Detection of RNA in Small Extracellular Vesicles from Plasma for Diseases Diagnosis by a Multisatellites@planets Molecular Imprinting Platform

Yuting Li, Yunqing Tang · 2025

Analytical Chemistry

Sensitive Detection of Exosomal Biomarkers via a Drop-Shaped Porous Microfluidic Chip for Potential Diagnosis of Alzheimer’s Disease

Huiying Xu, Yujing Zhang · 2025

Analytical Chemistry

Applications of machine learning-assisted extracellular vesicles analysis technology in tumor diagnosis

Liang Xu, Jing Li · 2025

Computational and Structural Biotec...

Clinical relevance of extracellular vesicles in cancer — therapeutic and diagnostic potential

David W. Greening, Rong Xu · 2025

Nature Reviews Clinical Oncology

Revolution of Circulating Tumor DNA: From Bench Innovations to Bedside Implementations

Xuehan Yan, Juncheng Su · 2025

Current Issues in Molecular Biology

Advancing Leukemia Management Through Liquid Biopsy: Insights into Biomarkers and Clinical Utility

Cíntia Nogueira Hollanda, Ana Cristina Moura Gualberto · 2025

Cancers

Exosomes in Precision Oncology and Beyond: From Bench to Bedside in Diagnostics and Therapeutics

Emile Youssef, Dannelle Palmer · 2025

Cancers

Liquid biopsy for human cancer: cancer screening, monitoring, and treatment

Hui Cao, Jinning Mao · 2024

MedComm

Exosomes: a promising avenue for cancer diagnosis beyond treatment

Zhu Wang, Qianqian Wang · 2024

Frontiers in Cell and Developmental...

SERS-Based Droplet Microfluidic Platform for Sensitive and High-Throughput Detection of Cancer Exosomes

Kwun Hei Willis Ho, Huang Lai · 2024

ACS Sensors

The Role of Circulating Tumor Cells as a Liquid Biopsy for Cancer: Advances, Biology, Technical Challenges, and Clinical Relevance

Tyler A. Allen · 2024

Cancers

Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy

Lijuan Wang, Haihong Lin · 2024

Frontiers in Oncology

Extracellular vesicles in nanomedicine and regenerative medicine: A review over the last decade

Saeid Moghassemi, Arezoo Dadashzadeh · 2024

Bioactive Materials

Revisiting the advances and challenges in the clinical applications of extracellular vesicles in cancer

Guangpeng He, Jiaxing Liu · 2024

Cancer Letters

A Platelet Reactivity ExpreSsion Score derived from patients with peripheral artery disease predicts cardiovascular risk

Jeffrey S. Berger, Macintosh G. Cornwell · 2024

Nature Communications

Multifunctional exosome-driven pancreatic cancer diagnostics and therapeutics

Sitong Zhang, Danyang Li · 2023

Extracellular Vesicle

Clinical significance of plasma PD-L1+ exosomes in the management of diffuse large B cell lymphoma

Peng Xu, Juan Liu · 2023

Annals of Hematology

Metrics

765

Citations

130

References

Details

Published: Apr 01, 2021
Vol/Issue: 32(4)
Pages: 466-477
License: View

Authors

W

W. Yu

Department of Stomatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

J

J. Hurley

School of Health and Human Sciences Southern Cross University Coffs Harbour NSW Australia

Funding

National Cancer Institute Award: CA069246

National Institutes of Health

Cite This Article

W. Yu, J. Hurley, D. Roberts, et al. (2021). Exosome-based liquid biopsies in cancer: opportunities and challenges. Annals of Oncology, 32(4), 466-477. https://doi.org/10.1016/j.annonc.2021.01.074

Exosome-based liquid biopsies in cancer: opportunities and challenges

You May Also Like